Health
Breakthrough Protocol Enhances Vaccine Effectiveness Studies Against Severe Respiratory Infections
2024-12-17
Author: Arjun
Introduction
In a significant advancement for public health, the European Centre for Disease Prevention and Control (ECDC) has released Version 4.0 of its core protocol aimed at studying vaccine effectiveness (CVE) against hospitalizations due to Severe Acute Respiratory Infections (SARI) confirmed by laboratory tests for SARS-CoV-2 and seasonal influenza.
Brasil (PT)
Canada (EN)
Chile (ES)
España (ES)
France (FR)
Hong Kong (EN)
Italia (IT)
日本 (JA)
Magyarország (HU)
Norge (NO)
Polska (PL)
Schweiz (DE)
Singapore (EN)
Sverige (SV)
Suomi (FI)
Türkiye (TR)